Resmed Inc. buy KeyCorp
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€258.40
Performance (%)
-14.91%
Price
30.07.26
€180.90
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -14.91%. This prediction currently runs until 31.10.26. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 7.264% | 7.264% |
| iShares Core DAX® | 3,90 % | 2,67 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % |
| iShares S&P 500 | -0,88 % | -1,49 % |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at KeyCorp from $298.00 to $299.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat